Franklin Resources’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $37M | Sell |
852,531
-23,545
| -3% | -$1.02M | 0.01% | 724 |
|
2025
Q1 | $32.7M | Buy |
876,076
+9,888
| +1% | +$369K | 0.01% | 737 |
|
2024
Q4 | $39.2M | Buy |
866,188
+5,199
| +0.6% | +$236K | 0.01% | 690 |
|
2024
Q3 | $48.1M | Sell |
860,989
-144,481
| -14% | -$8.06M | 0.01% | 618 |
|
2024
Q2 | $39.6M | Sell |
1,005,470
-29,910
| -3% | -$1.18M | 0.01% | 621 |
|
2024
Q1 | $68.8M | Sell |
1,035,380
-54,400
| -5% | -$3.61M | 0.02% | 472 |
|
2023
Q4 | $30.4M | Buy |
1,089,780
+92,423
| +9% | +$2.58M | 0.01% | 650 |
|
2023
Q3 | $21.2M | Buy |
+997,357
| New | +$21.2M | 0.01% | 725 |
|